On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
The new online Learning Center with new content can still be found under the “Training” folder on ...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...